Correlation Between Predictive Oncology and Nexgel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Nexgel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Nexgel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Predictive Oncology and Nexgel Inc, you can compare the effects of market volatilities on Predictive Oncology and Nexgel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Nexgel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Nexgel.

Diversification Opportunities for Predictive Oncology and Nexgel

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Predictive and Nexgel is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Nexgel Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexgel Inc and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Nexgel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexgel Inc has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Nexgel go up and down completely randomly.

Pair Corralation between Predictive Oncology and Nexgel

Given the investment horizon of 90 days Predictive Oncology is expected to generate 1.58 times less return on investment than Nexgel. In addition to that, Predictive Oncology is 1.54 times more volatile than Nexgel Inc. It trades about 0.04 of its total potential returns per unit of risk. Nexgel Inc is currently generating about 0.1 per unit of volatility. If you would invest  301.00  in Nexgel Inc on August 24, 2024 and sell it today you would earn a total of  26.00  from holding Nexgel Inc or generate 8.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Predictive Oncology  vs.  Nexgel Inc

 Performance 
       Timeline  
Predictive Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Nexgel Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nexgel Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Nexgel disclosed solid returns over the last few months and may actually be approaching a breakup point.

Predictive Oncology and Nexgel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Predictive Oncology and Nexgel

The main advantage of trading using opposite Predictive Oncology and Nexgel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Nexgel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexgel will offset losses from the drop in Nexgel's long position.
The idea behind Predictive Oncology and Nexgel Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios